Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Learn smart ways to save + get daily chances to win gift cards ...

South Carolina hasn’t had the season it wanted to have, at least up to this point. But Week 9 brings the potential for new hope and a new beginning, with the Gamecocks hosting No. 4 Alabama on ...

Somiya Adrees is a writer at GameRant. Her gaming journey began at a young age with classics like Super Mario Bros., Sonic the Hedgehog, and Disney's Aladdin in Nasira's Revenge (all of which she ...

Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

(Alliance News) - GSK PLC said Thursday its drug Blenrep has been approved by the US Food & Drug Administration for the treatment of adults with relapsed or refractory multiple myeloma, the third most ...

Belantamab mafodotin, a BCMA-targeting ADC, is approved for relapsed/refractory multiple myeloma after two prior therapies, showing significant PFS and OS benefits in the DREAMM-7 trial. The drug ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients whose prostate cancer had returned, a large international clinical trial has ...

Nomad has launched its latest Apple Watch accessory, the Stratos Band. It combines lightweight and durable titanium with FKM rubber for a breathable, comfortable, and durable watch band, unlike ...

The Cincinnati Bengals shared their NFL Week 8 uniform combo for their game Oct. 26 against the 0-7 New York Jets, declaring on social media that they're "getting in the Halloween spirit" with a black ...

Exelixis Inc. (NASDAQ:EXEL) stock is trading lower on Monday after the company shared detailed results from the STELLAR-303 Phase 3 trial. In June, the company said the study met one of its dual ...